Daily Express US on MSN2d
Ozempic and Zepbound linked to rare eye conditions that could cause blindnessA new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...
For example, Wegovy (a GLP-1 receptor agonist) and Zepbound (a dual agonist) are both FDA-approved specifically to treat weight loss, while Ozempic (another GLP-1 receptor agonist) is not FDA ...
People taking weight-loss drugs say they are losing their sight. Science is trying to figure out why
open image in gallery A small percentage of patients taking weight loss and diabetes drugs like Ozempic and Zepbound have experienced vision loss. However, scientists they there is not an ...
Eli Lilly (NYSE: LLY) has underperformed broader equities. While that's not much of an issue in the grand scheme of things, ...
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter despite missing the company’s initial sales expectations. Zepbound sales reached $1.9 billion in ...
Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...
Doctors at the University of Utah’s Moran Eye Center have reviewed cases of nine patients who developed vision problems while ...
Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback